Dr. Daniel Martin (US)
Daniel F. Martin, MD is Chair of the Cleveland Clinic Cole Eye Institute, the Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology, and Professor of Ophthalmology in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Martin completed medical school at The Johns Hopkins University School of Medicine followed by residency and chief residency in ophthalmology at Emory University School of Medicine. He completed a fellowship in Vitreoretinal Surgery and Diseases at Duke University Eye Center followed by a two-year fellowship in Uveitis and Ocular Immunology at the National Eye Institute of the National Institutes of Health. From 1993 to 2008, Dr. Martin served on the faculty of the Emory University School of Medicine, ultimately as tenured professor and as the Thomas M. Aaberg Professor of Ophthalmology. In 2008, Dr. Martin was appointed Chair of the Cleveland Clinic Cole Eye Institute and continues in that role today.
Dr. Martin’s primary research interest is in clinical trials and the evaluation of new treatments for retinal diseases. Dr. Martin serves as the Study Chair for the Comparison of AMD Treatments Trials (CATT) and also serves as the Network Chair for the Diabetic Retinopathy Clinical Research Network (DRCR). He has previously served as principal investigator for many AMD, diabetes, and uveitis trials including AREDS, SOCA, and MUST, and has served on numerous Data and Safety Monitoring Boards and Steering Committees. Dr Martin was extensively involved in the development of the ganciclovir implant and later valganciclovir for the treatment of CMV retinitis, serving as Study Chair for the clinical trials that resulted in FDA approval of both of these drugs.